Cargando…
Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients
BACKGROUND AND OBJECTIVES: Lidocaine 5% medicated plaster is the first lidocaine containing product for chronic use. As no previous investigations have been conducted to evaluate the population pharmacokinetics of long-term exposure to lidocaine 5% medicated plasters, further insights into the evalu...
Autores principales: | Bursi, Roberta, Piana, Chiara, Grevel, Joachim, Huntjens, Dymphy, Boesl, Irmgard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597703/ https://www.ncbi.nlm.nih.gov/pubmed/28078530 http://dx.doi.org/10.1007/s13318-017-0400-7 |
Ejemplares similares
-
Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia
por: Liedgens, Hiltrud, et al.
Publicado: (2013) -
5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability
por: Navez, Marie Louise, et al.
Publicado: (2015) -
Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series
por: Casale, Roberto, et al.
Publicado: (2014) -
Pharmacokinetics of Lidocaine and Its Metabolites Following Vaginal Administration of Lidocaine Gel to Healthy Female Subjects
por: Martell, Bridget, et al.
Publicado: (2016) -
Post-herpetic neuralgia
por: Tontodonati, Monica, et al.
Publicado: (2012)